Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Colorectal Carcinoma
100%
Endoscopic Surgery
80%
Neoplasm
79%
Crohn's Disease
77%
Colonoscopy
68%
Endoscopic Submucosal Dissection
68%
Patient with Crohn's Disease
66%
Diseases
65%
Balloon Enteroscopy
65%
Patient with Inflammatory Bowel Disease
60%
Inflammatory Bowel Disease
56%
Recurrent Disease
55%
Tumor
51%
Cohort Analysis
49%
Adenoma
48%
Ulcerative Colitis
46%
Endoscopy
44%
Colon
42%
Neuroendocrine Tumor
41%
Capsule Endoscopy
41%
Long-Term Outcome
40%
Hazard Ratio
38%
Retrospective Study
37%
Infliximab
35%
Polyp
35%
Colorectal Tumor
33%
Abdominal Cancer
32%
Endoscopic Mucosal Resection
30%
Bleeding
30%
Stricture
29%
Biopsy Technique
27%
Enteroscopy
26%
Odds Ratio
26%
Lymph Node Metastasis
26%
Computer Assisted Tomography
25%
Gastrointestinal Bleeding
24%
Patient with Ulcerative Colitis
22%
Intestine Preparation
21%
Obstruction
21%
Dysplasia
20%
Balloon Dilatation
20%
Predictive Factor
20%
Artificial Intelligence
19%
Median Follow Up
19%
MALT Lymphoma
19%
Cancer
19%
Clinical Feature
19%
Observational Study
18%
Argon Plasma Coagulation
17%
Scoring System
17%
Nursing and Health Professions
Colorectal Tumor
48%
Colonoscopy
42%
Adenoma
38%
Colorectal Carcinoma
35%
Patient with Inflammatory Bowel Disease
24%
Neoplasm
22%
Economic and Social Development
19%
Polyp
19%
Confidence Interval
16%
Helicobacter Infection
16%
Inflammatory Bowel Disease
15%
Intestine Preparation
13%
Bleeding
12%
Crohn's Disease
12%
Endoscopist
11%
Cohort Analysis
10%
Mass Screening
10%
Endoscopy
10%
Endoscopic Surgery
10%
Hazard Ratio
9%
Abdominal Cancer
9%
Capsule Endoscope
8%
Biopsy Forceps
8%
Percutaneous Endoscopic Gastrostomy
8%
Endoscopic Submucosal Dissection
8%
Syndrome
8%
Seasonal Variation
8%
Balloon Enteroscopy
8%
Proton Pump Inhibitor
8%
Eosin
8%
Haematoxylin
8%
Adherence
8%
Lymph Node Metastasis
8%
Suppository
8%
Body Weight Loss
8%
Sarcopenia
8%
Venous Thromboembolism
8%
Artificial Intelligence
8%
Polyposis
8%
Adverse Outcome
8%
Microsatellite Instability
8%
Ustekinumab
8%
Scoring System
8%
Cancer Incidence
8%
Infliximab
8%
Upper Gastrointestinal Bleeding
8%
Pancreas Cancer
8%
Diagnostic Value
8%
Odds Ratio
7%
Infection
7%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammatory Bowel Disease
49%
Infliximab
48%
Crohn's Disease
33%
Gastrointestinal Hemorrhage
24%
Proton Pump Inhibitor
19%
Rebamipide
19%
Therapeutic Drug Monitoring
18%
Hemoglobin
17%
Pharmacokinetic
17%
Prospective Cohort Study
16%
Syndrome
16%
Trough Level
15%
Colorectal Carcinoma
13%
Tumor Necrosis Factor
13%
Histamine H2 Receptor Antagonist
12%
Colorectal Adenoma
11%
C Reactive Protein
10%
Remission
9%
Adenoma
9%
Abdominal Cancer
9%
Colorectal Tumor
9%
Drug Antibody
8%
Hepatitis B Virus
8%
Prospective Study
8%
Bleeding
8%
Mercaptopurine
8%
Tioguanine
8%
Wernicke's Encephalopathy
8%
Trypsin Inhibitor
8%
Cancer Chemotherapy
8%
Hyaluronic Acid
8%
Alginic Acid
8%
Rat Model
8%
C Peptide
8%
Plasminogen Activator Inhibitor 1
8%
Antidiabetic Agent
8%
Antiplatelet
8%
Recurrence Risk
8%
Neoplasm
8%
Stenosis
8%
Maturity Onset Diabetes of the Young
8%
Alpha 1 Antitrypsin
8%
Protective Agent
8%
Gastrointestinal Tumor
8%
Blood Stasis
8%
Hepatitis B
8%
Recurrent Disease
8%
Polyposis
8%
Non-Steroidal Anti-Inflammatory Drug
8%
Intestine Flora
8%